|
Volumn 20, Issue 3, 2002, Pages 144-150
|
Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DOXORUBICIN;
M VAC PROTOCOL;
M-VAC PROTOCOL;
METHOTREXATE;
VINBLASTINE;
ADJUVANT CHEMOTHERAPY;
BLADDER TUMOR;
HUMAN;
REVIEW;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
DOXORUBICIN;
HUMANS;
METHOTREXATE;
URINARY BLADDER NEOPLASMS;
VINBLASTINE;
MLCS;
MLOWN;
|
EID: 0036675297
PISSN: 07244983
EISSN: None
Source Type: Journal
DOI: 10.1007/s00345-002-0252-9 Document Type: Review |
Times cited : (17)
|
References (36)
|